Backgrounds: Growth hormone (GH) was used for many years to increase ovarian response
in poor ovarian responders (PORs). Although meta-analysis suggested that GH therapy …

Low response of patients with diminished ovarian reserve to exogenous gonadotropins in
controlled ovarian stimulation (COS) protocols is one of the important problems of …

Background In vitro fertilization (IVF) patients receive various adjuvant therapies to enhance
success rates, but the true benefit is actively debated. Growth hormone (GH) and …

Research question Can a combination of time-lapse morphokinetic parameters and cumulus
cell gene expression in polycystic ovary syndrome (PCOS) women be used to predict …

Cumulus cells (CCs) play an important role in the regulation of female gamete development,
meiotic maturation, oocyte–sperm interaction, capacitation and acrosome reaction …

As women are increasingly delaying childbearing into their 30s and beyond, diminished
ovarian reserve (DOR) and advanced reproductive age (ARA) patients are bound to become …

Growth hormone (GH) has a long-standing history of use as an adjunctive therapy in the
treatment of poor ovarian response (POR), but the optimal dosage and timing remains …

Background In an effort to improve outcomes of in vitro fertilisation (IVF) cycles, the use of
growth hormone (GH) has been considered as adjuvant treatment in ovarian stimulation …

Background: Growth hormone (GH) has long been used as adjuvant treatment in ovarian
stimulation for in vitro fertilization (IVF), especially in poor responder (PR) patients. However …

Objective Growth hormone (GH) acts in both early and late follicular development to
stimulate the proliferation and differentiation of granulosa cells and to increase the …